Biotech Financing
Moonwalk Raises $70 Million as an Epigenetics Startup Moves Toward the Clinic
Moonwalk Biosciences raised a $70 million Series B to advance adipose-targeted RNAi medicines for obesity and cardiometabolic disease. Its epigenetics-based platform is…
Korsana Closes Cyclerion Merger With $380 Million War Chest for Alzheimer’s Drug Development
Korsana completed its merger with Cyclerion and closed a $380 million financing, giving the Alzheimer’s drug developer approximately $475 million in pro-forma…
Retro Biosciences’ $1.8 Billion Bet Moves From Ambition to Clinical Risk
A new financing values Retro at $1.8 billion before the round. Its first clinical program makes the scientific and execution risks easier…